The food as medicine market is estimated at USD 254.15 billion in 2026 and is projected to reach USD 400.81 billion by 2031, at a CAGR of 9.5% from 2026 to 2031. The worldwide food as medicine market is experiencing substantial growth due to rising awareness regarding the connection between nutrition and good health, the growing incidence of chronic diseases, and increasing demand for preventive healthcare solutions. Consumers are shifting toward functional food, medical food, nutraceuticals, personalized nutrition solutions, and therapeutic nutrition solutions. Medicated food plays a crucial role in managing chronic diseases, supporting immune health, maintaining metabolism, and promoting healthy aging. Advanced fields such as nutrigenomics, microbiomics, precision nutrition, and the use of bioactive ingredients have made it possible to create nutrition-based interventions for patients. In addition to that, government initiatives, increased expenditure on healthcare, digital health platforms, and rising consumer inclination towards natural science-driven healthcare solutions are contributing to market growth. The healthcare sector is increasingly moving toward a preventive and nutrition-centric model of health, making food as medicine an integral part of the modern-day health ecosystem.
Market Size and Forecast:
- Market Size Value in 2025: USD 230.00 Billion
- Market Size Value in 2026: USD 254.15 Billion
- Revenue Forecast in 2031: USD 400.81 Billion
- Growth Rate: CAGR of 9.5% from 2026 to 2031
- Base year: 2025
- Forecast period: 2026–2031
- The Asia Pacific region is estimated to account for the largest share (26.8%) of the food as medicine market in 2026.
- The functional food segment is estimated to lead the market with a share of 37.7% in 2026
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94945332
By product type, functional foods segment to lead market during forecast period
By product type, the functional foods segment is estimated to lead the food as medicine market due to its high consumer acceptability, ease of integration into daily diets, and growing awareness of preventative medicine solutions. Functional foods like fortified foods, probiotics yogurt drinks, functional beverages, protein-added foods, and fortified snack foods are being consumed to improve digestive function, enhance the immune system, promote cardiovascular health, and boost general well-being. The growth of this segment is driven by increasing health awareness, the clean label trend, and new innovations in products from medicated food manufacturing companies.
By function, gastrointestinal health segment to lead market during forecast period.
By function, the gastrointestinal health segment is estimated to account for the largest share of the food as medicine market. This is due to the higher levels of consumer awareness about gastrointestinal health and growing demands for preventive healthcare. The robust scientific backing of gut health and its connection to the immune system, metabolism, and overall wellness is driving the use of probiotics, prebiotics, synbiotics, and fiber-based functional food products. Furthermore, the rising incidences of gastrointestinal diseases, including IBS, IBD, constipation, and digestive disorders, along with technological advancements in the field of microbiome-based nutrition products, are making gastrointestinal health the most dominant functional category within the food as medicine market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94945332
Asia Pacific to be fastest-growing regional market for food as medicine during forecast period.
The Asia Pacific region is anticipated to experience the fastest growth in the global food as medicine market. This surge is attributed to heightened awareness of health care, the rising prevalence of chronic diseases, a growing middle-class population, and increasing disposable incomes in countries such as China, India, Japan, and South Korea. The fast pace of urbanization, change in food habits, and increasing demand for prevention-oriented health care and personalized nutritional therapy have been driving the demand for functional foods, nutraceuticals, and medical nutrition products. Other factors adding impetus to the market’s growth include favorable government policies toward nutrition and wellness, and investments made by market participants.
Leading Food as Medicine Companies:
Some of the major players in the food as medicine market include Nestlé Health Science (Switzerland), Danone (France), Abbott Nutrition (US), Reckitt Mead Johnson (UK), FrieslandCampina (Netherlands), Herbalife (US), Amway (US), Novonesis (Denmark), Yakult Honsha Co., Ltd. (Japan), Unilever (UK), Otsuka Holdings (Japan), Probi AB (Sweden), Church & Dwight Co., Inc. (US), Meiji Holdings (Japan), and Jamieson Wellness (Canada).
Recent Developments in the Food as Medicine Industry:
- June 2026: Danone announced the acquisition of MADE Group, an Australian health food company known for high protein, gut health, and plant-based nutrition brands. The deal strengthens Danone’s healthy nutrition portfolio in the Asia Pacific region and supports its strategy to expand in fast-growing health and wellness food categories.
- March 2026: Meiji launched enhanced Meiji Step and Meiji Step Raku Raku Cube follow-up milk products containing Bifidobacterium OLB6378 and zinc to support gut health, immunity, and healthy development in children aged 1 to 3 years.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/food-as-medicine-market-94945332.html
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Food as Medicine Market worth $400.81 billion by 2031, at a CAGR of 9.5%
